News and reflections from the world of AI

    Aiforia releases Aiforia® Studies, a pioneering GLP-compliant AI-assisted image analysis workflow for non-clinical histology studies

    Aiforia Technologies Plc, Press Release, March 6, 2024 at 09:00 a.m. EET
    Written by Aiforia

    Aiforia signs a licensing agreement with the Mayo Clinic for an AI model that improves prediction of colorectal cancer recurrence

    Aiforia Technologies Plc, Press release, January 2, 2024 at 10.00 a.m. EET Aiforia has entered into an exclusive licensing agreement with the Mayo ...
    Written by Aiforia

    Aiforia signs a deal with an Italian hospital in Catania

    Aiforia Technologies Plc, Press Release, December 27, 2023 at 01:00 p.m. EET
    Written by Aiforia
    December 21, 2023

    Looking back on 2023: A year of important milestones

    Dear customers, shareholders, and our team, As we stand at the threshold of a new year, I wanted to take a moment to review the events of 2023 and express my gratitude for your continued support and hard work that the team has done. It has been a year of important milestones for Aiforia as the first deployments of our clinical AI-solutions were kicked-off in key markets.
    Written by Aiforia
    October 20, 2023

    Aiforia initiates path to secure its first regulatory approval in the United States – application to the FDA anticipated in 2024

    Aiforia Technologies Plc, Press Release, October 20, 2023 at 10:00 a.m. EEST
    Written by Aiforia
    September 18, 2023

    Aiforia complies with applicable HIPAA regulations, enabling it to provide solutions to a broader range of customers in the US

    Aiforia Technologies Plc, Press Release, 18 September 2023 at 09:00 a.m. EEST
    Written by Aiforia
    1 2 3 4 5